| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO
1 company
Watts Ryan J. is a President And CEO at DNLI. Recent filings cover 0 purchases and 122 sales.
Our model assigns Watts Ryan J. a strong insider score of 70/100, based on 33 past trades. Over a 12-month horizon, 84.4% of those trades were profitable, with an average 12-month return of +26.0%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 35,198 | $16.50 | $580,767.00 | -10.6% | +12.6% | - | |
| Jul 9, 2025 | DNLI Denali Therapeutics Inc. | President And CEO | Sale+OE | 495,282 | $15.00 | $7,429,230.00 | -66.2% | -0.7% | +81.4% | |
| Jan 7, 2025 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 36,916 | $20.34 | $750,955.02 | -12.7% | -45.2% | -20.0% | |
| Oct 18, 2024 | DNLI Denali Therapeutics Inc. | President And CEO | Sale+OE | 40,000 | $27.69 | $1,107,600.00 | -14.5% | -21.5% | -39.6% | |
| Aug 20, 2024 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 2,260 | $23.79 | $53,765.40 | -0.9% | +2.2% | -38.6% | |
| Feb 13, 2024 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 9,589 | $17.29 | $165,793.81 | -3.9% | +13.1% | +22.0% | |
| Jan 9, 2024 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 7,818 | $19.78 | $154,640.04 | -0.3% | -3.5% | +7.6% | |
| Jan 5, 2024 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 17,483 | $19.43 | $339,694.69 | -0.8% | -1.8% | +9.9% | |
| Aug 21, 2023 | DNLI Denali Therapeutics Inc. | President And CEO | Sell | 2,309 | $22.59 | $52,160.31 | -0.1% | -17.5% | +1.6% | |
| Aug 10, 2023 | DNLI Denali Therapeutics Inc. | President And CEO | Sale+OE | 2,526 | $25.03 | $63,225.78 | -0.1% | -16.7% | -7.6% |